References

  1. Breurec S, Berlioz-Arthaud A, Baumann E, Miegeville M, Billaud E. Evaluation of toxoplasmosis seroprevalence among 2416 women of childbearing age followed at the Pasteur Institute of New Caledonia. Bull Soc Pathol Exot. 2004;97(4):271-3. PubMed | Google Scholar

  2. Dubey J. Toxoplasmosis in animals and humans. CRC Press, Boca Raton, FL. 2009; Second Edition: 313 p. PubMed | Google Scholar

  3. Moncada PA, Montaya NJ. Toxoplasmosis in the fetus and newborn: an update on prevalence, diagnosis and treatment. Expert Rev Anti Infect Ther. 2012;10(7):815-28. PubMed | Google Scholar

  4. Hill D, Dubey JP. Toxoplasma gondii: Transmission, diagnosis, and prevention. Clin Microbiol Infect, European Society of Clinical Infectious Diseases; 2002;8(10):634-40. Google Scholar

  5. Galvan-Ramirez ML, Troyo R, Roman S, Calvillo-Sanchez C, Bernal-Redondo R. A systematic review and meta-analysis of Toxoplasma gondii infection among the Mexican population. Parasit Vectors. 2012;5:271. Google Scholar

  6. Montoya JG, Liesenfeld. Toxoplasmosis. Lancet. 2004;363(9425):1965-7. PubMed | Google Scholar

  7. Galvan-Ramirez ML, Rincon A B-RR. Diagnostic of opportunistic parasites in liver transplantation, in Volume 1.1st edition. Edited by de Bruyn O, Stephane P New York: Nova; Parasitol Res trends. 2010;1:210-25. Google Scholar

  8. Galván Ramirez ML, Covarrubias X, Rodríguez R, Troyo R, Alfaro N, Correa D. Toxoplasma gondii antibodies in Mexican blood donors. Transfusion. 2005;45(2):281-2. PubMed | Google Scholar

  9. Flegr J, Prandota J, Sovickova M, Israili ZH. Toxoplasmosis: A global threat, Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries. PLoS One. 2014;9(3):e90203. PubMed | Google Scholar

  10. Halonen S K, Weiss LM. Toxoplasmosis. Handb clin Neurol. 2013;114(8):125-45. PubMed | Google Scholar

  11. Pappas G, Roussos N FM. Toxoplasmosis snapshots: Global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital, toxoplasmosis Original Research Article. Int J Parasitol. 2009;3(1):1385-94. Google Scholar

  12. Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol. 2000;30(12-13):1217-58. PubMed | Google Scholar

  13. Dubey JP, Jones JL. Toxoplasma gondii infection in humans and animals in the United States. Int J Parasitol. 2008;38(2008):1257-78. PubMed | Google Scholar

  14. Hernández-Cortazar I, Acosta-Viana KY, Ortega-Pacheco A, Guzman-Marin ES. Review Toxoplasmosis in Mexico: Epidemiological Situation in Humans and Animals. Rev Inst Med Trop são paulo. 2015;57(2):93-103. Google Scholar

  15. Torgerson PR, Mastroiacovo P. The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ. 2013;91(7):501-8. PubMed | Google Scholar

  16. Opsteegh MA, Kortbeek TM, Havelaar AH, Van-Der-Giessen JWB. Intervention strategies to reduce human Toxoplasma gondii disease burden. Clin Infect Dis. 2015;60(1):101-7. Google Scholar

  17. Luft BJ1 RJ. Toxoplasmic encephalitis in AIDS. Clin Infect Dis. 1992;15(2):211-22. Google Scholar

  18. Laboudi M, El Mansouri B, Rhajaoui M. The role of the parity and the age in acquisition of Toxoplasmosis among pregnant women in Rabat - Morocco-. Int J Innov Appl Stud. 2014;6(3):488-92. Google Scholar

  19. Touhami A. Le RDAD 2011: Profil et Strategies de Lutte Contre la Pauvrete au Maroc: Etat des Lieux. Le Programme des Nations Unies pour le Développement (PNUD). 2011; 36p. Google Scholar

  20. Guessous-Idrissi N, Lahlou D, Sefiani R, Benmira A. Toxoplasmosis and rubella in Moroccan women: Results of a serological survey. Pathol Biol Paris. 1984;32(7):761-5. PubMed | Google Scholar

  21. El Mansouri B, Rhajaoui M, Sebti F, Amarir F, Laboudi M, Bchitou R, et al. Seroprevalence of toxoplasmosis in pregnant women in Rabat, Morocco. Bull Soc Pathol Exot. 2007;(4):289-90. PubMed | Google Scholar

  22. Barkat A. Prévalence des femmes enceintes non immunisées contre la toxoplasmose. Arch Pédiatrie. 2010;17(6):75. Google Scholar

  23. Marcolino PT, Silva D a, Leser PG, Camargo ME, Mineo JR. Molecular markers in acute and chronic phases of human toxoplasmosis: determination of immunoglobulin G avidity by Western blotting. Clin Diagn Lab Immunol. 2000;7(3):384-9. PubMed | Google Scholar

  24. Robert-Gangneauxx F, Viieljeuf C, Tourte-Schaefer C D-CJ. Apport de l'avidité des anticorps dans la datation d'une séroconversion toxoplasmique. Ann Biol Clin (Paris). 1998;56(5):586-9. Google Scholar

  25. Laboudi M, Sadak A. Serodiagnosis of Toxoplasmosis: the effect of measurement of IgG avidity in Pregnant Women in Rabat in Morocco. Acta Trop. 2017;172:139-42. PubMed | Google Scholar

  26. Laboudi M, El Mansouri B, Sebti F, Amarir F, Coppitiers Y, Rhajaoui M. Facteurs de risque d'une sérologie toxoplasmique positive chez la femme enceinte au Maroc. Parasite. 2009;16(1):71-2. PubMed | Google Scholar

  27. Berger F, Goulet V, Le Strat Y, Desenclos J. Toxoplasmose chez les femmes enceintes en France: évolution de la séroprévalence et de l'incidence et facteurs associes, 1995-2003. BEH thématique. 2008;14-15:117-21. Google Scholar

  28. Messerer L, Bouzbid S, Mokhtar B. Seroprevalence of toxoplasmosis in pregnant women in Annaba , Algeria. Rev Epidemiol Sante Publique. 2014;62(2014):160-165. PubMed | Google Scholar

  29. Fakhfakh N, Kallel K, Ennigro S, Kaouech E, Belhadj S, Chaker E et al. Facteurs de risque pour Toxoplasma gondii et statut immunitaire des femmes parturientes: relation de cause à effet. Tunis Med. 2013;91(3):188-90. Google Scholar

  30. Elsheikha HM. Congenital toxoplasmosis, priorities for further health promotion action. Public Heal Rev. 2008;122(4):335-53. PubMed | Google Scholar

  31. Ministère de la santé du Maroc. Mise en oeuvre de la déclaration politique sur le VIH/sida, Rapport. Ministère de la santé du Maroc. 2015; 96 p.

  32. Addebbous A, Adarmouch L, Tali A, Laboudi M, Amine M, Aajly L et al. IgG anti-toxoplasma antibodies among asymptomatic HIV-infected patients in Marrakesh-Morocco. Acta Trop. 2012;123(1):49-52. PubMed | Google Scholar